IFNA1 and systemic lupus erythematosus: Type I interferons (IFN) induce an antiviral state in immune cells and stimulate dendritic cell differentiation in an immunogenic rather than tolerogenic manner are potential mediators in various autoimmune diseases and especially in systemic lupus erythematosus (SLE) (1) as well as in type I interferonopathies (2).